Cassiopea S.P.A.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Cosmo Dermatos SRL (to 2015)
8
Ending by 2030
Jul 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 30, 2027The maintenance fee for High Concentration Formulation (US 11,883,415) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
- 2 fees due Sep 26 to 30, 2027 · next Sep 26
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,486,458 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone and/or Its 9,11-Dehydroderivatives In force · High confidence | In force | High confidence | |
| US 10,716,796 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives In force · High confidence | In force | High confidence | |
| US 12,337,002 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives In force · Medium confidence | In force | Medium confidence | |
| US 10,159,682 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone and/or its 9,11-Dehydroderivatives In force · High confidence | In force | High confidence | |
| US 10,166,245 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives In force · High confidence | In force | High confidence | |
| US 11,938,141 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives In force · Medium confidence | In force | Medium confidence | |
| US 11,207,332 | Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone And/Or Its 9,11-Dehydroderivatives In force · High confidence | In force | High confidence | |
| US 8,785,427 | Enzymatic Process for Obtaining 17 Alpha- Monoesters of Cortexolone And/Or Its 9,11- Dehydroderivatives In force · High confidence | In force | High confidence | |
| US 9,011,933 | Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds In force · High confidence | In force | High confidence | |
| US 10,603,327 | High Concentration Formulation In force · High confidence | In force | High confidence |
Also on record, not counted in the 13: 1 patent in force now held by others · 5 lapsed for an unpaid fee · 5 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 2 abandoned